With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...
Keep Reading →
August 12 - News
I don't know which is worse: The fact that insider trading was legal for some of our nation's wealthiest politicians...
Keep Reading →
August 12 - News
In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)'s extended phase 3 program for its inhaled insulin, Afrezza, is likely to produce ...
Keep Reading →
August 12 - News
Over the past year, the battle over cancer treatments has heated up considerably. Big pharma companies such as Amgen, Inc. (NASDAQ:AMGN), Pfizer Inc.
Keep Reading →
August 7 - News
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Keep Reading →
August 7 - News
In America, 33.5% of adults over the age of 20 have high LDL (“bad”) cholesterol levels, according to the CDC.
Keep Reading →
August 7 - News
A recent EvaluatePharma report estimated the market for prescribed drugs will increase at an annual rate of 3.8% to $895 billion from 2012 to 2018.
Keep Reading →
August 6 - News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been stuck is share purgatory for a number of years.
Keep Reading →
August 6 - News
Believe it or not, 2013 is getting close to being two-thirds of the way over. Many pharmaceutical firms have enjoyed great stock returns and nice profits thus far in the year.
Keep Reading →
August 6 - News
Chronic obstructive pulmonary disease (COPD) is America’s third leading cause of death.
Keep Reading →
August 5 - News
Zoetis will release its quarterly report on Tuesday, and investors will get their first look at the company as a completely independent business entity.
Keep Reading →
August 5 - News
The biotechnology industry is one of the riskiest places to put your money. However, when companies get everything right, the fortunes made there are usually massive.
Keep Reading →
August 5 - News
During the past decade, healthcare has been one of the most stable and consistent performers among all industries.
Keep Reading →
August 5 - News
In the hunt for sustainable dividend yields, investors have rushed into the stocks of major pharmaceutical companies.
Keep Reading →
August 3 - News
Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings on Wednesday.
Keep Reading →
August 1 - News
Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)'s recent earnings report is a key confirmation of a shifting market in the treatment of multiple sclerosis...
Keep Reading →
August 1 - News
High yields aren't everything when you're searching for the perfect dividend stock.
Keep Reading →
August 1 - News
The good news was that the big pharmaceutical company beat earnings estimates. Merck & Co., Inc.
Keep Reading →
July 31 - News
The company broke open a bombshell on Monday when it announced that it would break its business into three new divisions -- two focused around drugs, vaccines, and consumer products...
Keep Reading →
July 31 - News
Today, let's look at investing giant Donald Yacktman, who founded Yacktman Asset Management in 1992.
Keep Reading →
July 31 - Hedge Funds
So much for the stock market gains that dominated most of today's trading.
Keep Reading →
July 30 - News
This morning the Dow Jones Industrial Average (INDEXDJX:.DJI)'s two big drug companies and a number of smaller drug-related companies announced earnings.
Keep Reading →
July 30 - News
AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) announced last week that they are making another attempt at U.S.
Keep Reading →
July 30 - News
The Dow Jones Industrial Average is kicking off the new week in the red as a disappointment from the flourishing housing sector pressures the markets.
Keep Reading →
July 29 - News
It's easy to forget that AbbVie Inc (NYSE:ABBV) is technically only seven-months old.
Keep Reading →
July 29 - News
The aging population as well as the higher number of people who will receive benefits under new healthcare laws should combine to produce rising profits for a variety of companies...
Keep Reading →
July 29 - News
After last week, when eight of the Dow Jones Industrial Average's 30 components reported earnings, this week may seem slow, with only four companies releasing their second-quarter...
Keep Reading →
July 29 - News
We often take sleep, the number of hours we get to sleep, or the quality of sleep we get, for granted.
Keep Reading →
July 29 - News
Despite some negative news, mainly related to reimbursement issues and excess stock booking, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) recently gained solid momentum due to a...
Keep Reading →
July 28 - News
Eli Lilly & Co. (NYSE:LLY) will release its quarterly report tomorrow, and recent share-price declines show that investors are somewhat nervous about the company's prospects.
Keep Reading →
July 26 - News
For Eli Lilly & Co. (NYSE:LLY), history is repeating itself once again.
Keep Reading →
July 25 - News
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout.
Keep Reading →
July 24 - News
The healthcare sector has been one of the best sectors for dividend hunters -- most of the companies operating in the sector generate massive cash flow and payout a large chunk...
Keep Reading →
July 24 - News
Uncertainty creates opportunity for long-term investors, and there is a lot of uncertainty in the healthcare sector right now.
Keep Reading →
July 24 - News
Biotech is booming these days. But that's not a new story by any means. Biotech stocks as a group have done very well over the past several years.
Keep Reading →
July 24 - News
We have a bona fide biotech soap opera going on these days. Spurned love. Possible romance. Disgruntled suitor. And, of course, the unknown villain.
Keep Reading →
July 24 - News
The recent rally in shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) may suggest investors are regaining some confidence in this pharmaceutical manufacturer.
Keep Reading →
July 23 - News
Shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST) exploded upward on Friday, finishing up over 9%.
Keep Reading →
July 22 - News
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
Keep Reading →
July 22 - News
According to multiple reports , Harvard researchers Timothy Henrich and Daniel Kuritzkes have recently noted a surprising side-effect to cancer treatments performed on two separate...
Keep Reading →
July 22 - News
There's little denying that the technological, research, and medicinal aspects of patient care are improving at breakneck speed.
Keep Reading →
July 22 - News
In an industry where buyouts are commonplace and small-cap biotechs burn through cash rapidly, optimizing operating cash flow can be essential to a company's financial health.
Keep Reading →
July 19 - News
The "people familiar with the matter" are out in full force spouting off about who's bidding for Onyx Pharmaceuticals, Inc.
Keep Reading →
July 19 - News
The pharmaceutical sector is mainly about the pipeline of new products and patents.
Keep Reading →
July 19 - News
Most recently, executives working for the U.K.-based GlaxoSmithKline plc (ADR) (NYSE:GSK) in China have been accused of, and confessed to, serious corruption and tax-related ...
Keep Reading →
July 19 - News
The story of the second quarter for Novartis AG (ADR) (NYSE:NVS) offered mixed results for investors. The company's net sales were up 1%, and EPS was down 6% year over year.
Keep Reading →
July 18 - News
Amid sluggish sales growth, the Pharmaceutical Industry giants are struggling with declining revenues and profits.
Keep Reading →
July 18 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
July 18 - News
Sustainability and a strong pipeline are the two tests that best evaluate a pharmaceutical company. Merck & Co., Inc. (NYSE:MRK) scores high on both counts.
Keep Reading →
July 18 - News
One of the strongest market sectors so far in 2013 has been pharmaceuticals.
Keep Reading →
July 17 - News
